Deutsche Bank Starts Kindred Healthcare (KND) at Buy

Deutsche Bank initiated coverage on Kindred Healthcare (NYSE: KND) with a Buy rating and a price target of $30.00. Analyst Dana Nentin sees pockets of opportunity in the the PAC industry due to an improving regulatory landscape, favorable supply/demand trends, and increased consolidation opportunities.

"We believe KND shares are attractive due to (1) its positioning as one of the most diversified, PAC providers with the greatest breadth of service offerings in the secular shift towards a more integrated, coordinated health care system; (2) recent developments which position the company for growth, with upside risks to Gentiva deal synergies; (3) positioning of its portfolio to mitigate the impact of the LTACH patient criteria; and (4) very attractive equity sensitivity to free cash flow and deleveraging," said Nentin.

For an analyst ratings summary and ratings history on Kindred Healthcare click here. For more ratings news on Kindred Healthcare click here.

Shares of Kindred Healthcare closed at $21.77 yesterday.

You May Also Be Interested In

• Correction: Citi Upgrades Sirius XM Radio (SIRI) to Neutral
• DNB ASA (DNB:NO) (DNHBY) PT Raised to NOK205 at JPMorgan
• UBS Upgrades Galp Energia (GALP:SM) (GLPEY) to Neutral